Aug 2026· Journal of Cardiovascular Imaging· Vol 34· 0 citations· 66 references
Medicine
TL;DR
A scoping review of AI applications in predicting clinical outcomes related to angiographic procedures, including diagnosis, risk stratification, and postprocedural monitoring finds promising capabilities in outcome prediction within coronary angiography.
Abstract
Artificial intelligence (AI) is emerging as a transformative tool in cardiovascular imaging, particularly in coronary angiography. With the growing interest in precision medicine, AI offers the potential to enhance clinical decision-making by improving diagnostic accuracy, predicting outcomes, and guiding interventions. This scoping review aims to examine the current landscape of AI applications in predicting clinical outcomes related to angiographic procedures, including diagnosis, risk stratification, and postprocedural monitoring. A total of 59 relevant studies published between 2015 and 2025 were included in this review. The selection was based on predefined inclusion criteria focused on AI-based models applied in coronary artery disease diagnosis, outcome prediction and restenosis detection. The studies were reviewed for the AI techniques used, clinical endpoints targeted, model performance, validation strategies, and limitations. Four primary themes were identified: (1) prediction of adverse cardiovascular events such as myocardial infarction and mortality; (2) detection of hemodynamically significant stenosis; (3) prediction of in-stent restenosis; and (4) identification of coronary arteries. Machine learning algorithms, especially random forests, support vector machines, and convolutional neural networks, have been commonly used. Many models have demonstrated superior performance compared to traditional statistical methods. However, limitations such as small sample sizes, lack of external validation, retrospective designs, and concerns about data privacy were frequently observed in these studies. AI demonstrates promising capabilities in outcome prediction within coronary angiography. Despite current limitations, its integration into clinical practice is feasible with prospective, multicentric studies and standardized validation frameworks. Ethical considerations and regulatory oversight will be crucial in ensuring safe and effective implementation.
It was demonstrated that machine learning (ML) and deep learning (DL) models consistently outperformed conventional cardiovascular risk prediction tools, achieving area under the receiver operating characteristic curve (AUC) values ranging from 0.80-0.99 across various cardiovascular conditions.
N. Muruganandan, P. Prathiba, Khyati Rajeshkumar Patel et al.· International Journal of Res...· 0 citations
The clinician–AI synergy can accelerate diagnosis and individualize treatment in pericardial and myocardial diseases and justify dual-chamber ICD implantation and personalized transplantation risk assessment.
M. Galkina, O. V. Fatenkov, J. R. Vagizov et al.· Manager Zdravookhranenia· 0 citations
It is emphasized that successful integration of AI into cardiovascular care requires rigorous prospective validation, transparent algorithmic governance, equitable data representation, and human-AI collaborative frameworks, provided its meaningful clinical implication is demonstrated through improved patient outcomes.
Xu Xia, Wasim Ullah Khan, Q. Khan et al.· Trends in cardiovascular med...· 0 citations
Recent advances in machine learning applications for PCI prognostic prediction are reviewed, encompassing predictive targets including in-hospital mortality, major adverse cardiovascular events, bleeding complications, and long-term survival.
Jian Chen, Lun-Hua Shen, Peng-Fei Xia et al.· Journal of Clinical Medicine...· 0 citations
AI-assisted LVO detection has the potential to improve the speed and coordination of acute stroke care, particularly for proximal anterior circulation occlusions, but should augment rather than replace clinician interpretation.
Ishaan Bakshi· The Operating Room Global Jo...· 0 citations
AI-CAC represents a promising approach for scaling atherosclerotic cardiovascular disease risk stratification and may support the evolution of the CAC score itself by integrating plaque characteristics, distribution and complementary imaging biomarkers to support more personalised preventive strategies rather than rely...
Valerie F. McDonald, Shyon Parsa, Domenico Mastrodicasa et al.· BMJ digital health & AI· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.